Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Sawai Pharmaceutical Co Ltd

+ Add to Watchlist

4555:JP

7,010.0 JPY 130.0 1.89%

As of 02:00:00 ET on 04/24/2015.

Snapshot for Sawai Pharmaceutical Co Ltd (4555)

Open: 6,950.0 Day's Range: 6,940.0 - 7,050.0 Volume: 273,600
Previous Close: 6,880.0 52wk Range: 5,630.0 - 7,900.0 1-Yr Rtn: +15.13%

Stock Chart for 4555

No chart data available.
  • 4555:JP 7,010.0
  • 1D
  • 1M
  • 1Y
6,880.0
Interactive 4555 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4555

Current P/E Ratio (ttm) 19.7209
Estimated P/E(03/2015) 18.4707
Relative P/E vs. TPX 1.0682
Earnings Per Share (JPY) (ttm) 355.4600
Est. EPS (JPY) (03/2015) 379.5190
Est. PEG Ratio 3.3042
Market Cap (M JPY) 267,344.49
Shares Outstanding (M) 38.14
30 Day Average Volume 232,020
Price/Book (mrq) 2.3496
Price/Sale (ttm) 2.5239
Dividend Indicated Gross Yield 1.43%
Cash Dividend (JPY) 50.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 23.36%
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4555

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4555

SAWAI PHARMACEUTICAL CO., LTD. develops, manufactures, wholesales prescription and generic drugs such as antibiotics, anticancer agents, and circulatory agents.

Hiroyuki SawaiChairmanMitsuo SawaiPresident
Takashi IwasaManaging Executive OfficerHarumasa ToyaManaging Executive Officer
More Company Profile & Key Executives for 4555

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil